These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 7616401

  • 1. Does adenosine receptor blockade mediate caffeine-induced rotational behavior?
    Garrett BE, Holtzman SG.
    J Pharmacol Exp Ther; 1995 Jul; 274(1):207-14. PubMed ID: 7616401
    [Abstract] [Full Text] [Related]

  • 2. The effects of dopamine agonists on rotational behavior in non-tolerant and caffeine-tolerant rats.
    Garrett BE, Holtzman SG.
    Behav Pharmacol; 1995 Dec; 6(8):843-851. PubMed ID: 11224389
    [Abstract] [Full Text] [Related]

  • 3. Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats.
    Pinna A, Fenu S, Morelli M.
    Synapse; 2001 Mar 01; 39(3):233-8. PubMed ID: 11284438
    [Abstract] [Full Text] [Related]

  • 4. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists.
    Cauli O, Morelli M.
    Psychopharmacology (Berl); 2002 Jul 01; 162(3):246-54. PubMed ID: 12122482
    [Abstract] [Full Text] [Related]

  • 5. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation.
    Quarta D, Borycz J, Solinas M, Patkar K, Hockemeyer J, Ciruela F, Lluis C, Franco R, Woods AS, Goldberg SR, Ferré S.
    J Neurochem; 2004 Nov 01; 91(4):873-80. PubMed ID: 15525341
    [Abstract] [Full Text] [Related]

  • 6. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD, Pierce RC.
    Neuroscience; 2006 Oct 13; 142(2):451-61. PubMed ID: 16844308
    [Abstract] [Full Text] [Related]

  • 7. Interactions between adenosine and dopamine receptor antagonists with different selectivity profiles: Effects on locomotor activity.
    Collins LE, Galtieri DJ, Collins P, Jones SK, Port RG, Paul NE, Hockemeyer J, Müller CE, Salamone JD.
    Behav Brain Res; 2010 Aug 25; 211(2):148-55. PubMed ID: 20211657
    [Abstract] [Full Text] [Related]

  • 8. Blockade of globus pallidus adenosine A(2A) receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D(1) or D(2) dopamine receptor agonists.
    Simola N, Fenu S, Baraldi PG, Tabrizi MA, Morelli M.
    Synapse; 2008 May 25; 62(5):345-51. PubMed ID: 18297692
    [Abstract] [Full Text] [Related]

  • 9. Ergoline derivative LEK-8829-induced turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine.
    Sprah L, Zivin M, Sket D.
    J Pharmacol Exp Ther; 1999 Mar 25; 288(3):1093-100. PubMed ID: 10027846
    [Abstract] [Full Text] [Related]

  • 10. Influence of previous exposure to levodopa on the interaction between dizocilpine and dopamine D1 and D2 agonists in rats with 6-hydroxydopamine-induced lesions.
    Boldry RC, Chase TN, Engber TM.
    J Pharmacol Exp Ther; 1993 Dec 25; 267(3):1454-9. PubMed ID: 7903390
    [Abstract] [Full Text] [Related]

  • 11. Motor stimulant effects of caffeine in 6-hydroxydopamine-lesioned rats are dependent on previous stimulation of dopamine receptors: a different role of D1 and D2 receptors.
    Fenu S, Morelli M.
    Eur J Neurosci; 1998 May 25; 10(5):1878-84. PubMed ID: 9751157
    [Abstract] [Full Text] [Related]

  • 12. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
    Criswell HE, Johnson KB, Mueller RA, Breese GR.
    J Pharmacol Exp Ther; 1993 May 25; 265(2):1001-10. PubMed ID: 8098756
    [Abstract] [Full Text] [Related]

  • 13. Prior treatment (priming) with caffeine sensitizes D2-dopamine-mediated contralateral rotational behavior in 6-hydroxydopamine-lesioned rats.
    Pollack AE, Dimitrov KD, Drake JD.
    Pharmacology; 2010 May 25; 86(2):73-8. PubMed ID: 20639686
    [Abstract] [Full Text] [Related]

  • 14. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT, White FJ.
    Synapse; 1994 May 25; 17(1):43-61. PubMed ID: 7913772
    [Abstract] [Full Text] [Related]

  • 15. In vivo administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor messenger RNA inhibits D2 dopamine receptor-mediated behavior and the expression of D2 dopamine receptors in mouse striatum.
    Zhou LW, Zhang SP, Qin ZH, Weiss B.
    J Pharmacol Exp Ther; 1994 Feb 25; 268(2):1015-23. PubMed ID: 8113958
    [Abstract] [Full Text] [Related]

  • 16. Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated rats.
    Carta AR, Pinna A, Cauli O, Morelli M.
    Synapse; 2002 Jun 01; 44(3):166-74. PubMed ID: 11954048
    [Abstract] [Full Text] [Related]

  • 17. The role of the phosphatidyinositol-linked D1 dopamine receptor in the pharmacology of SKF83959.
    Zhen X, Goswami S, Friedman E.
    Pharmacol Biochem Behav; 2005 Apr 01; 80(4):597-601. PubMed ID: 15820529
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of adenosine antagonists in two models of parkinsonian tremor.
    Trevitt J, Kawa K, Jalali A, Larsen C.
    Pharmacol Biochem Behav; 2009 Nov 01; 94(1):24-9. PubMed ID: 19602422
    [Abstract] [Full Text] [Related]

  • 19. Haloperidol-induced catalepsy is influenced by adenosine receptor antagonists.
    Malec D.
    Pol J Pharmacol; 1997 Nov 01; 49(5):323-7. PubMed ID: 9566031
    [Abstract] [Full Text] [Related]

  • 20. Effects of SCH 58261, an adenosine A(2A) receptor antagonist, on quinpirole-induced turning in 6-hydroxydopamine-lesioned rats. Lack of tolerance after chronic caffeine intake.
    Popoli P, Reggio R, Pèzzola A.
    Neuropsychopharmacology; 2000 May 01; 22(5):522-9. PubMed ID: 10731627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.